Pharmacy- Page 4

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Bristol-Myers Squibb Announces Dividend Increase

The FINANCIAL -- The Board of Directors of Bristol-Myers Squibb Company declared an increase of 2.5% percent in the company’s quarterly dividend, beginning in the first quarter of 2019.

by The FINANCIAL

December 7, 2018

1 min read

Pharmacy

Bayer to Drive Value Creation

The FINANCIAL -- The Bayer Group aims to significantly enhance its performance in the coming years and has set itself ambitious growth and margin targets through 2022.

by The FINANCIAL

December 5, 2018

2 mins read

Pharmacy

Updated Results from Two Studies in Newly-diagnosed Acute Myeloid Leukaemia

The FINANCIAL -- Roche announced new data from the Venclexta/Venclyxto (venetoclax) clinical development programme, including longer-term results from the phase III MURANO study in people with previously treated chronic lymphocytic leukaemia (CLL) and updated data from two phase Ib/II studies in people

by The FINANCIAL

December 4, 2018

2 mins read

Pharmacy

Bristol-Myers Squibb to Transfer $3.8 billion in U.S. Pension Liabilities

The FINANCIAL -- Bristol-Myers Squibb Company announced it will transfer $3.8 billion of U.S. pension obligations through a full termination of its U.S. Retirement Income Plan.

by The FINANCIAL

December 4, 2018

1 min read

Pharmacy

Global Resolution Secures Patient Access to Sandoz Biosimilar Hyrimoz

The FINANCIAL -- Sandoz, a Novartis division and one of the global leaders in biosimilars, announced a global resolution of all intellectual property related litigation with AbbVie concerning the proposed Sandoz biosimilar Hyrimoz for reference medicine Humira.

by The FINANCIAL

October 12, 2018

1 min read

Pharmacy

New analysis estimates the positive impact of Jardiance

The FINANCIAL -- Novel results based on data from the landmark EMPA-REG OUTCOME trial were published in the journal Circulation which suggest that treatment with Jardiance positively impacts life expectancy in adults with type 2 diabetes and established cardiovascular disease, Boehringer Ingelheim

by The FINANCIAL

October 11, 2018

1 min read

Pharmacy

U.S. FDA Grants Priority Review to Astellas’ New Drug Application for Gilteritinib for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

The FINANCIAl -- TOKYO – May 29, 2018 – Astellas Pharma Inc. announced, that the U.S. Food and Drug Administration has accepted, with Priority Review, the company’s New Drug Application for gilteritinib for the treatment of adult patients who have relapsed or

by The FINANCIAL

May 30, 2018

1 min read

Pharmacy

World Health Assembly delegates agree new five-year strategic plan

The FINANCIAL -- World Health Assembly delegates today agreed an ambitious new strategic plan for the next five years.

by The FINANCIAL

May 23, 2018

1 min read

Pharmacy

Lilly Announces Agreement To Acquire ARMO BioSciences

The FINANCIAL -- Eli Lilly and Company and ARMO BioSciences, Inc. on May 10 announced a definitive agreement for Lilly to acquire ARMO for $50 per share, or approximately $1.6 billion, in an all-cash transaction.

by The FINANCIAL

May 11, 2018

2 mins read

Pharmacy

Bayer receives approval for Eylea in China

The FINANCIAL -- Bayer announced on May 11 that Eylea (aflibercept solution for injection into the eye) has been approved by the Chinese regulatory authorities for the treatment of visual impairment due to neovascular (wet) age-related macular degeneration (wAMD).

by The FINANCIAL

May 11, 2018

2 mins read